We are live on ! Find out more
CGC icon

Canopy Growth

0.6843 USD
+0.0162
2.42%
At close Updated Oct 27, 4:00 PM EDT
Pre-market
After hours
0.6900
+0.0057
0.83%
1 day
2.42%
5 days
-5.64%
1 month
-26.05%
3 months
-25.97%
6 months
-42.97%
Year to date
-42.5%
1 year
-48.16%
5 years
-99.46%
10 years
-99.76%
 

About: Canopy Growth Corp is a cannabis company that produces, distributes, and sells a diverse range of cannabis and cannabis-related products for adult-use and medical purposes under a portfolio of distinct brands in Canada. The Company supplies cannabis products in Canada, Europe, and Australia. It is focused on the medical and adult-use cannabis markets in Canada, offering a broad portfolio of brands and formats for medical cannabis patients and adult-use consumers. The Company operates through two reportable segments: Cannabis, which generates maximum revenue and includes the production, distribution, and sale of cannabis and cannabis-related products, and Storz & Bickel, which includes the production, distribution, and sale of vaporizers and accessories.

Employees: 1,128

News

Positive
Neutral
Negative
Sentiment 3-Months
Positive 35.3%
Neutral 51%
Negative 13.7%
Positive
Zacks Investment Research
6 hours ago
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
Canopy Growth Corporation (CGC) closed the most recent trading day at $0.68, moving +2.42% from the previous trading session.
Canopy Growth Corporation (CGC) Beats Stock Market Upswing: What Investors Need to Know
Neutral
Business Wire
1 day ago
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced the voting results from its annual general and special meeting of shareholders convened on September 25, 2026, and adjourned to and reconvened on October 23, 2026 (the “Meeting”). A total of 154,837,897 common shares of the Company (the “Shares”), representing 36.60% of.
Canopy Growth Announces Results of 2026 Annual General and Special Meeting of Shareholders
Neutral
MarketBeat
4 days ago
Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board
Canopy Growth NASDAQ: CGC shareholders approved all matters presented at the company's reconvened 2026 Annual General and Special Meeting, including a share-consolidation authorization, the election of five directors and the appointment of MNP LLP as auditor for fiscal 2027.
Canopy Growth Shareholders Approve Reverse Split Authority, Elect Board
Neutral
Business Wire
5 days ago
Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, will release its financial results for the second quarter fiscal year 2027 ended September 30, 2026, before financial markets open on November 6, 2026. Following the release of its financial results, Canopy Growth will host an audio webcast with Luc Mongeau, CEO, and Tom Stewart, CFO,.
Canopy Growth to Report Second Quarter Fiscal 2027 Financial Results on November 6, 2026
Neutral
Zacks Investment Research
6 days ago
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
Canopy Growth Corporation (CGC) closed at $0.67 in the latest trading session, marking a -6.67% move from the prior day.
Canopy Growth Corporation (CGC) Stock Declines While Market Improves: Some Information for Investors
Negative
The Motley Fool
9 days ago
Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.
Despite last December's Executive Order, efforts to reschedule marijuana remained stymied by bureaucratic gridlock. Canopy Growth shares have tumbled on this regulatory inaction, but that's not the largest issue at hand for the company.
Trump's Marijuana Order Is Stuck at the DEA. Here's What That Means for Canopy Growth.
Neutral
The Motley Fool
12 days ago
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Canopy Growth maintains a strategic focus on premium cannabis products and European medical distribution. Tilray Brands has expanded into the craft beverage and wellness markets to diversify its revenue streams.
Canopy Growth vs. Tilray Brands: Which Cannabis Stock Is a Better Buy in 2026?
Negative
Zacks Investment Research
13 days ago
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market
Canopy Growth Corporation (CGC) closed at $0.71 in the latest trading session, marking a -6.27% move from the prior day.
Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market
Positive
Zacks Investment Research
13 days ago
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Neutral
Business Wire
14 days ago
Canopy Growth's Smiths Falls Facility Becomes Canada's Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
SMITHS FALLS, Ontario--(BUSINESS WIRE)--Canopy Growth Corporation (“Canopy Growth”, “our”, “we” or the “Company”) (TSX: WEED) (Nasdaq: CGC), a leading global company committed to bettering lives through cannabis, today announced that its Smiths Falls, Ontario facility (“Smiths Falls”) has received European Union Good Manufacturing Practice (“EU GMP”) certification for manufacturing and packaging activities from the Tübingen Regional Council (Regierungspräsidium Tübingen), Baden-Württemberg's com.
Canopy Growth's Smiths Falls Facility Becomes Canada's Only EU GMP-Certified Site Combining Softgel Manufacturing With Primary Packaging of Softgels, Oral Liquids and Dried Cannabis Flower
Price charts implemented using Lightweight Charts™